MGL-3196

CAT: 0026-B3010-5Size: 5 mgDry Ice: NoHazardous: No
CAT#:0026-B3010-5Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
A selective thyroid hormone receptor β agonist with EC₅₀ values of 0.21 and 3.74 µM for THRβ and THRα, respectively. It significantly lowers non-HDL-C and liver TG in hypercholesterolemic rat and rabbit models at doses where there is no effect on TSH levels or the central thyroid axis. It significantly decreased LDL-C by up to 30%, and showed a statistical trend to reduce TG up to 60% in healthy volunteers, at once daily oral dose of 50 mg or higher for 2 weeks. It does not show THR-α mediated gene expression in a rat heart model indicating low potential for cardiac adverse effects. In vitro assays are predictive of lower off target actions. It shows an IC₂₀ of ~30 μM for blockage of the hERG channel and IC₅₀ >50 μM for CYP3A4/5 and CYP2C19. Formulations containing MGL-3196 are in clinical trials for the treatment of dyslipidemia.
Shipping Conditions
RT
Storage Conditions
-20ºC
Shelf Life
36months

Related Products

CatalogName

Alternative Products

CatalogName
MBS3606598-01MGL-3196
A13248-1MGL-3196 1mg
A13248-2MGL-3196 2mg
A13248-10MGL-3196 10mg
A13248-5MGL-3196 5mg
A13248-50MGL-3196 50mg
A13248-500MGL-3196 500mg
A13248-25MGL-3196 25mg
A13248-100MGL-3196 100mg
C12104-01Resmetirom (MGL-3196)

Popular Products